Why is 'this deal is accretive' not the same statement as 'this is a good deal'? Give a one-sentence explanation an MD would accept.
General educational practice only. This is not an actual, confidential, leaked, or firm-provided interview question. Check important technical details against primary learning materials.
The answer
An accretive deal simply means the acquirer’s first-year EPS goes up because the earnings it bought, minus financing costs, yields more per share than before. That is a mechanical accounting outcome. It says nothing about whether the price paid makes economic sense.
A deal can be financed with cheap debt, be heavily accretive on day one, yet destroy value because the premium was too high relative to the present value of synergies. Conversely, a strategically brilliant acquisition of a high-growth target can be dilutive in year one and still be the right call. The MD wants you to separate the optics of EPS from real value creation.
Accretion is a financing and accounting test; a good deal is one where the present value of synergies exceeds the premium paid. That distinction matters because an accretive deal might still mean the acquirer overpaid for those earnings, while a dilutive deal might be buying a future earnings stream that isn’t captured in today’s net income.
Accretion / dilution
| Acquirer standalone net income | 300 |
| + Target net income | 80 |
| + After-tax synergies | 15 |
| − After-tax incremental interest | (10) |
| Pro forma combined net income | 385 |
| Acquirer standalone EPS | $3.00 |
| Pro forma share count | 125 |
| Pro forma EPS | $3.08 |
| Accretion | 2.7% |
Also asked as
- In plain English, without writing a single formula, explain why an acquisition can raise or lower the acquirer's EPS.
- State the all-stock P/E shortcut for accretion/dilution and explain precisely why it only works for 100% stock deals with no synergies.
- An acquirer earning a 6% earnings yield buys a target with a 4% earnings yield at the offer price, funded entirely in stock. Is the deal accretive or dilutive, and why?
- Explain, using the earnings-yield framework rather than a formula, why an all-cash deal funded from a low-interest bank account is almost always accretive.
- A target's headline P/E looks cheap relative to the acquirer's, but the acquirer is paying a 45% control premium. Why might the deal still be dilutive despite the favorable-looking multiple comparison?
- Target net income is $90M, bought for a $1,500M equity purchase price, funded 50% with new debt at 7% pre-tax and 50% with cash on hand earning 2.5% pre-tax; tax rate 25%. Using only the earnings-yield intuition (no share count math needed), is this accretive or dilutive, and by roughly how much (state the spread in percentage points)?
- An acquirer at a 22x P/E considers two potential targets, both earning $50M of net income: Target X priced at 14x, Target Y priced at 26x, both all-stock deals with no synergies. Explain the direction of accretion/dilution for each, and then explain why an interviewer might follow up by asking whether the 22x acquirer's own valuation is 'expensive' or 'cheap' relative to fundamentals, and why that question matters beyond the arithmetic.
- A board is told a proposed all-debt-financed deal is accretive by 3%, driven entirely by a low borrowing rate, with the target priced at a full 25x multiple. Explain the specific risk the year-one accretion number is hiding, and what additional analysis you would present alongside it.
- Rates rise sharply, simultaneously increasing the acquirer's cost of debt and compressing the acquirer's own trading multiple. Using the earnings-yield framework, explain qualitatively what happens to the accretion math for (a) a debt-financed deal and (b) a stock-financed deal, and why the two do not necessarily move in the same direction by the same amount.
Practice this topic with rubric-grounded grading inside IB Atlas.
Start freeGet all 125 practice prompts as one PDF.
General educational prompts with study explanations for offline review. They are not firm-provided or confidential questions.
Keep going
The rest of this topic
Accretion and dilution